Moneycontrol PRO
Loans
HomeNewsBusinessMarketsClosing Bell: Nifty ends below 11,500, Sensex falls 222 points; auto stocks slip
Live now
auto refresh

Closing Bell: Nifty ends below 11,500, Sensex falls 222 points; auto stocks slip

The Sensex was down 222.14 points at 38164.61, while Nifty was down 64.10 points at 11456.90.

March 22, 2019 / 15:35 IST
  • Closing Bell: Nifty ends below 11,500, Sensex falls 222 points; auto stocks slip
    The 10 most valued domestic companies together added a whopping Rs 4,04,068.05 crore in market valuation last week, with RIL and HDFC Bank leading the gains. Here are the top 10 firms according to their market capitalisation for the week ended April 9:
    Moneycontrol.com
  • IndexPricesChangeChange%
    Sensex80,364.94-61.52 -0.08%
    Nifty 5024,634.90-19.80 -0.08%
    Nifty Bank54,461.0071.65 +0.13%
    Nifty 50 24,634.90 -19.80 (-0.08%)
    Mon, Sep 29, 2025
    Biggest GainerPricesChangeChange%
    Interglobe Avi5,707.00146.00 +2.63%
    Biggest LoserPricesChangeChange%
    Axis Bank1,132.20-21.80 -1.89%
    Best SectorPricesChangeChange%
    Nifty PSU Bank7390.75129.30 +1.78%
    Worst SectorPricesChangeChange%
    Nifty Auto26436.55-47.95 -0.18%


  • March 22, 2019 / 15:34 IST

    Market Close

    : Benchmark indices ended lower but off day's low on Friday with Nifty finished below 11,500 level.

    At close, the Sensex was down 222.14 points at 38164.61, while Nifty was down 64.10 points at 11456.90. About 1009 shares have advanced, 1665 shares declined, and 143 shares are unchanged.

    NTPC, L&T, Asian Paints, JSW Steel and Hindalco Industries were top gainers on the Nifty, while losers were Bharti Infratel, BPCL, Tata Motors, HPCL and Reliance Industries.

    Except infra all other sectoral indices ended in red led by Nifty PSU bank, auto, energy, pharma, metal and IT. BSE Midcap fell 0.60 percent, while Smallcap index fell 0.40 percent.

  • March 22, 2019 / 15:27 IST

    TVS Electronics to sell entire holding in subsidiary

    : The company has entered into share purchase agreements for disposing its entire shareholding in Benani Foods, subsidiary of the company.

  • March 22, 2019 / 15:20 IST

    Canara Bank issues Foreign Currency Bond under MTN

    The bank launched a issuance of 5 year Senior Unsecured Bonds (Medium Term Notes) to the extent of USD 400 million under Medium Term Note (MTN) Programme, through its London branch. It is priced at 5 year US Treasury plus 170 bps carrying a coupon of 3.875% fixed payable half yearly.

  • March 22, 2019 / 15:12 IST

    No observations for Cadila's Ahmedabad facility

    The USFDA inspected the pharmaceutical technology centre (PTC), at Ahmedabad, dedicated to new product development of various niche dosage forms including solid oral, parenteral, pulmonary, oncology, ointment & creams and transdermal, from March 18 to 22, 2019.

    At the end of the inspection, no observations (483) have been issued.

  • March 22, 2019 / 14:54 IST

    Aurionpro wins prestigious order

    Company's subsidiary in Singapore has won a prestigious project, in banking and fintech space, from one of the largest banks in Singapore, having significant operations in Southeast Asia including in key markets of Malaysia and China.

  • March 22, 2019 / 14:39 IST
  • March 22, 2019 / 14:26 IST

    Market Update

    The benchmark indices are erased all its gains and trading at day's low point with Nifty around 11,450 level.

    The Sensex is down 254.13 points at 38132.62, while Nifty is down 75.60 points at 11445.40. About 928 shares have advanced, 1551 shares declined, and 135 shares are unchanged.

  • March 22, 2019 / 14:05 IST

    Zydus receives final approval from the USFDA

    Zydus Cadila has received the final approval from the USFDA to market Lurasidone Hydrochloride Tablets USP (US RLD-Latuda Tablets), in the strengths of 20 mg, 40 mg, 60 mg, 80 mg and 120 mg.

  • March 22, 2019 / 13:51 IST

    Caplin Point gets USFDA nod

    Caplin Point Laboratories Caplin Steriles, a wholly owned subsidiary of Caplin Point Laboratories has been granted final approval by the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Glycopyrrolate injection USP.

  • March 22, 2019 / 13:23 IST

    Jefferies on Maruti Suzuki

    : Research house maintained buy rating on the stock with a target at Rs 7,600 per share. It feels that access to Toyota's technology will be key to long-term prospects.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347